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http://www.actaneurocomms.org/content/2/1/38RESEARCH Open AccessGolgi fragmentation precedes neuromuscular
denervation and is associated with endosome
abnormalities in SOD1-ALS mouse motor neurons
Vera van Dis1†, Marijn Kuijpers1,2†, Elize D Haasdijk1, Eva Teuling1, Scott A Oakes3, Casper C Hoogenraad1,2
and Dick Jaarsma1*Abstract
Background: Fragmentation of stacked cisterns of the Golgi apparatus into dispersed smaller elements is a feature
associated with degeneration of neurons in amyotrophic lateral sclerosis (ALS) and some other neurodegenerative
disorders. However, the role of Golgi fragmentation in motor neuron degeneration is not well understood.
Results: Here we use a SOD1-ALS mouse model (low-copy Gurney G93A-SOD1 mouse) to show that motor
neurons with Golgi fragmentation are retrogradely labeled by intramuscularly injected CTB (beta subunit of
cholera toxin), indicating that Golgi fragmentation precedes neuromuscular denervation and axon retraction.
We further show that Golgi fragmentation may occur in the absence of and precede two other pathological
markers, i.e. somatodendritic SOD1 inclusions, and the induction of ATF3 expression. In addition, we show that
Golgi fragmentation is associated with an altered dendritic organization of the Golgi apparatus, does not depend on
intact apoptotic machinery, and is facilitated in transgenic mice with impaired retrograde dynein-dependent transport
(BICD2-N mice). A connection to altered dynein-dependent transport also is suggested by reduced expression of endosomal
markers in neurons with Golgi fragmentation, which also occurs in neurons with impaired dynein function.
Conclusions: Together the data indicate that Golgi fragmentation is a very early event in the pathological cascade in ALS
that is associated with altered organization of intracellular trafficking.
Keywords: Amyotrophic Lateral Sclerosis (ALS), Protein aggregation, Endosome trafficking, Dynein, Transgenic mouse
model, SOD1Introduction
Death and disappearance of neurons is a constant hallmark
of neurodegenerative disorders, such as Alzheimer's disease
and other dementia's, Parkinson's disease, and amyotrophic
lateral sclerosis (ALS). A large body of evidence indicates
that protein aggregation and proteotoxicity are central
early pathogenic steps in these disorders, but how these
events ultimately result in neuronal malfunction and de-
generation is yet poorly established for most disorders
[1,2]. Various mechanisms involving improper function of
specific organelles, in particular mitochondria and the
endoplasmic reticulum (ER), or disrupted function of* Correspondence: d.jaarsma@erasmusmc.nl
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unless otherwise stated.cellular processes such as protein quality control, intra-
cellular trafficking, cell death signaling, synaptic signaling
or calcium homeostasis have been proposed to contribute
to neuronal degeneration [2-5]. Neuropathological studies
have also revealed abnormalities in the Golgi apparatus in
a variety of neurodegenerative diseases [6-8]. The Golgi ap-
paratus is a highly dynamic organelle involved in proces-
sing and sorting of lipids and proteins. Its morphology
depends on a large variety of protein components and cel-
lular processes [9-13]. Accordingly, Golgi morphology can
alter under a variety of physiological conditions such as cell
division, growth, and altered metabolic demands [9], as
well as pathological conditions, including impaired ER
function, disruption of intracellular transport, altered lipid
metabolism, excessive excitation, DNA damage, and activa-
tion of cell death pathways [6,14-19].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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rons of ALS patients, where it may occur in 10-50% of
motor neurons in sporadic and SOD1-ALS patients
[6,20,21] and up to 70% of the motor neurons in some pa-
tients with familial ALS and ALS-like disorders [22,23].
The occurrence of Golgi fragmentation correlates with
nuclear-to-cytoplasmic redistribution of TDP-43 and the
presence of TDP-43 positive inclusions in sporadic ALS
motor neurons [24]. Golgi fragmentation also correlates
with the presence of inclusions in other ALS forms includ-
ing optineurin-ALS and SOD1-ALS [21-23], but its role in
motor neuron degeneration is not understood.
Golgi fragmentation also occurs in transgenic ALS ro-
dent models [25-27]. It has been identified as an early fea-
ture in motor neurons in transgenic mice that express
human SOD1 with an ALS-linked mutation and develop
an ALS like motor neuron disorder [27-29]. To further
understand the pathological significance of Golgi fragmen-
tation in ALS, in the present study we have precisely char-
acterized the relationship between Golgi fragmentation
and other early pathological events in the SOD1-ALS
mouse model. Our data show that Golgi fragmentation
precedes the appearance of somatodendritic SOD1 inclu-
sions, activation of the injury transcription factor ATF3,
neuromuscular denervation and axon retraction. We fur-
ther show that Golgi fragmentation also occurs in the ab-
sence of a functional mitochondrial apoptotic pathway, is
greatly facilitated in neurons with impaired dynein func-
tion and is associated with endosomal abnormalities.
These data suggest that Golgi fragmentation reflects al-
tered organization of intracellular trafficking, perhaps in
response to specific aggregated SOD1 complexes.
Materials and methods
Transgenic mice
All animal experiments were approved by the Erasmus
University animal care committee, and performed in ac-
cordance with the guidelines the "Principles of labora-
tory animal care" (NIH publication No. 86–23), and the
European Community Council Directive (86/609/EEC).
Transgenic mice expressing a human genomic SOD1
construct with the G93A mutation were originally derived
from the Gurney G1 mice, but because of a reduction in
the transgene copy number (8 instead of ~20 transgene
copy numbers per haploid genome) show a delayed dis-
ease onset and are termed G1del mice [30-32]. G1del mice
are maintained under standard housing conditions in a
FVB/N background by mating hemizygote males with
non-transgenic females, non-transgenic offspring serving
as controls [31].
Neuron-specific mice carrying the cDNA of G93A-
mutant hSOD1 cloned into the Thy1.2 expression cas-
sette were generated as described [31]. In this study we
used tissue from T3hSOD1 double transgenic micegenerated by crossing Thy1hSOD1-G93A mice derived
from founder T3 with line N1029 wild-type hSOD1
overexpressing mice [31].
BICD2-N (line BN1) mice are transgenic for a construct
expressing the N-terminus of Bicaudal D2 coupled to GFP
(GFP-BICD2-N) and cloned into the Thy1.2 expression
vector [17]. BN1/G1del mice were obtained by inter-
crossing hemizygous G1del and BN1 mice as described
[17]. In this study we analyzed Golgi fragmentation in
spinal cord sections from G1del, G1del/BN1 and BN1
killed at 28 weeks of age with 4–6 mice per genotype.
Both G1 del and G1del/N1 mice showed mild-to-moderate
muscle weakness of hind limb function.
For one experiment we used paraffin embedded spinal
cord tissue from 90 days old high copy (fast) G1 mice (car-
rying ~20 hSOD1-G93A transgene copy numbers, see
above) crossed with mice deficient for the mitochondrial
apoptotic pathway in the central nervous system, termed
DKO mice. DKO mice were Bak-null in the whole body
(Bak−/−) and Bax-null in the central nervous system (Baxf/f/
Nestin-Cre; see [33] for details). We analyzed archival sec-
tions from 3 mice per genotype (non-tg, DKO, G1del,
G1del/DKO).
Antibodies
Primary antibodies (supplier; dilutions) used in this
study are:
Rabbit anti-ATF3 (Santa Cruz; IHC and IF 1:1000), goat-
anti-choline acetyltransferase (ChAT, Millipore, 1:500), goat
anti-Cholera toxin B subunit (CTB; List Biological laborator-
ies, 1:5000), rabbit-anti-CGRP (Calbiochem, IF, 1:10.000),
human-anti EEA1 (gift from Dr. M.J. Fritzler, IF: 1:500 [34]),
mouse-anti GM130 (BD Biosciences, 1:200), rabbit-anti
GM130 (antibody M07, gift from Dr. M. Lowe [35], 1:1000),
mouse anti GRASP65 (gift from Dr. M. Lowe [35], 1:200),
rabbit-anti-GRASP-1 (Millipore, 1:500), rat anti-Mac-2
(Cedarlane, 1:2000), mouse-anti p115 (BD Biosciences,
1:500), sheep anti-hSOD1 (Calbiochem; IF, 1:5000), rabbit-
anti unfolded SOD1 (USOD, gift from Dr. A. Chakrabartty
[36], 1:1000), rabbit anti-SOD1 exposed dimer interface
(SEDI, gift from Dr. J. Robertson [37], 1:1000), mouse anti-
ubiquitin (clone FK2; Affinity BioReagents, Golden, CO;
1:2000, rabbit anti-ubiquitin (DAKO, 1:1000).
Secondary antibodies used for IF or ICC were Alexa-
488, −568 or −633- conjugated goat-anti mouse or goat-
anti rabbit antibodies from Molecular Probes; or FITC,
Cy3 or Cy5 donkey-anti-rabbit, donkey-mouse or donkey-
goat antibodies from Jackson Laboratories; all antibodies
were used at 1:400. Biotinylated goat-anti-rabbit or anti-
mouse IgG (Vector) were used at 1:400.
Immunocytochemical and histochemical analyses
For immunocytochemistry and immunofluorescence,
mice were anaesthetized with pentobarbital and perfused
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glutaraldehyde (0.05%). The lumbar and cervical spinal
cord were carefully dissected out and postfixed overnight
in 4% paraformaldehyde. Routinely, spinal cord tissue was
embedded in gelatin blocks [38], sectioned at 40 μm with
a freezing microtome, and sections were processed, free-
floating, using a standard avidin–biotin–immunoperoxi-
dase complex method (ABC, Vector Laboratories, USA)
with diaminobenzidine (DAB, 0.05%) as the chromogen,
or single-, double- and triple-labelling immunofluores-
cence. Immunoperoxidase-stained sections were analysed
and photographed using a Leica DM-RB microscope and
a Leica DC300 digital camera. Sections stained for im-
munofluorescence were analyzed with a Leica DM-RB epi-
fluorescence microscope and Zeiss LSM 510 and LSM700
confocal laser scanning microscopes.
Cholera toxin B-fragment (CTB) retrograde tracing
Mice were anaesthetized, immobilized, and Cholera toxin
B-fragment (CTB) (0.5% in 2.5 μl saline) was injected in
the gastrocnemic muscle of 15, 20 and 25 weeks old G1del
mice and non-transgenic littermates (Figure 1A). 4 days
following injections mice were perfused with 4% parafor-
maldehyde with or without glutaraldehyde (0.05%), and
their spinal cords were embedded in gelatin blocks, sec-
tioned at 40 μm, and further processed for immunohistolo-
gical procedures. To obtain an estimate of the number of
retrogradely labeled motor neurons, one in 10 sections was
immunoperoxidase-DAB stained for CTB and used for
counting CTB-positive cells with the aid of an Olympus
microscope fitted with a LucividTM miniature monitor and
NeurolucidaTM software(MicroBrightField, Colchester, VT,
USA). Only CTB-positive cells whose nucleus was partially
or entirely present in the section, but did not contact the
surface of the sections, were counted.
Quantitative analysis of immunofluorescence images
The proportion of CTB and GM130-positive motor neu-
rons was determined in sections from G1del mice of 15
(n = 3) and 20 weeks (n = 3), 4 sections/mouse using a
Leica DM-RB epifluorescence microscope with a 63x ob-
jective. First, all large neurons (diameter >20 μm) in the
ventral horn both ipsi- and contralateral of the injection
were scored for Golgi fragmentation, and subsequently
using the same sections CTB-positive cells were scored
for Golgi fragmentation.
Dendritic GM130 labelling was examined with a Zeiss
LSM 510 laser scanning microscope using sections from
20 weeks old G1del mice. CTB-labeled motor neurons
were selected for analysis on the basis of the presence of
at least 3 dendrites within the plane of section, and with at
least 2 of these dendrites having the first branching point
in the section. Confocal stacks of CTB and GM130 stacks
were collected, and cells were analyzed for the occurrenceof Golgi fragmentation and the presence of dendritic
GM130 labeling. A total of 24 and 14 motor neurons with
normal and fragmented Golgi apparatus, respectively,
were analyzed (Additional file 1: Table S1).
For analysis of fluorescence intensities, images were col-
lected using a Zeiss LSM 510 confocal laser scanning micro-
scope with 63x objective. Fluorescence intensities were
determined using Metamorph image analysis software.
Statistical analyzes were performed with MS Excel or
Graphpad Prism software using Student’s t-test and one-
way ANOVA.
Primary neuron cultures and transfection
Primary rat hippocampal neurons were plated at a density
of 75.000 on 18 mm glass coverslips and transfected at
DIV13 with GFP, GFP-p150-cc, GFP-BICD2-N or GFP-p50
using Lipofectamine-2000 (Qiagen) as described [17,39].
After 2 days of transfection, neurons were fixed and stained
with human anti-EEA1 antibodies. Representative cells
were imaged using a Zeiss LSM 510 confocal laser scanning
microscope with a x63 oil immersion objective. The num-
ber of particles were analyzed using Metamorph software.
Results
Retrograde labeling of motor neurons with Golgi
fragmentation after intramuscular injection of cholera toxin
B (CTB)
The present study has been mainly performed with G1del
mice (also termed G1slow) that carry 8 copies of a human
G93A-mutant SOD1 and develop weakness in one or
more limbs from age 24–34 weeks of age and die of fatal
paralysis between 30–41 weeks of age [29,32]. The onset
of Golgi fragmentation in G1del mice is at about 14–15
weeks of age [29]. In view of evidence that degeneration of
the distal axon is an early event in SOD1-ALS mice pre-
ceding the loss of motor neurons [40-42], we first exam-
ined whether motor neurons with Golgi fragmentation
have an intact axon. For this purpose, we performed retro-
grade tracing of Choleratoxin B (CTB) injected in the gas-
trocnemic muscle (Figure 1A), and double stained lumbar
spinal cord sections for CTB and the cis-Golgi matrix pro-
tein GM130 [43]. CTB is taken up via endocytosis after
binding to the ganglioside GM1 in motor nerve endings
and then retrogradely transported to the cell bodies,
where it accumulates in the trans-Golgi, lysosomes, and
the cytoplasm [44,45]. The number of CTB labeled
motor neurons was the same as in non-transgenic litter-
mates in G1del mice at 15 and 20 weeks, and was re-
duced in G1del mice at 25 weeks (Figure 1B), consistent
with the onset of motor neuron loss at 25 weeks [29].
CTB labeling was present throughout the soma and
dendrites. Typically, motor neurons of G1del mice showed
small vacuolar expansions in the distal portion of the den-
drites (Figure 1C), reflecting vacuolated mitochondria [46].
Figure 1 (See legend on next page.)
van Dis et al. Acta Neuropathologica Communications 2014, 2:38 Page 4 of 15
http://www.actaneurocomms.org/content/2/1/38
(See figure on previous page.)
Figure 1 Retrograde labeling of motor neurons with Golgi fragmentation following intramuscular injections of CTB. A-C) CTB (0.5% in
2.5 μl saline) is injected in the gastrocnemic muscle to retrogradely label motor neurons (A). B) Dot plot showing the number of CTB-positive
motor neurons counted in each tenth section. Note reduced number of CTB-positive cells in 25 week old G1del mice compared to age matched
non-transgenic mice (P < 0.05, unpaired Student's t-test). C) Maximal projection of confocal stack (optical section 22 μm) of CTB-labeled motor
neuron illustrating small vacuoles in the distal dendrite (insert). D) Double-labeling confocal image of CTB and GM130 showing cross sections of
4 retrogradely labeled motor neurons. A large proportion of CTB localizes to the Golgi apparatus. The motor neuron below has fragmented Golgi.
E) Bar graph showing the proportion of motor neurons with Golgi fragmentation in all large ventral horn neurons (GM130) and the CTB labeled
population. F-I) Representative images of a CTB-labeled motor neuron with normal Golgi apparatus (F), fragmented Golgi (G), and fragmented
Golgi with no or little CTB (H, I). J) Representative example of a proximal motor neuron dendrite with GM130-positve ribbons that stop at the
branching point (arrow). K) Two motor neurons with Golgi fragmentation showing fragmented Golgi in the proximal dendrites up to the first
branching point (arrows and insert). Bars: 20 μm (C, D), 10 μm (K), 5 μm (F, J).
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mentation (Figure 1D-K). Importantly, the proportion of
retrogradely CTB-labeled motor neurons with Golgi frag-
mentation is the same as the proportion of Golgi fragmen-
ted motor neurons in the total population of motor
neurons (Figure 1E). This indicates that Golgi fragmenta-
tion does not interfere with retrograde labeling.
In CTB positive motor neurons with a normal Golgi ap-
paratus, a proportion of CTB codistributed with GM130,
consistent with retrograde trafficking of CTB to the Golgi
apparatus (Figure 1D). Accordingly, also in the majority of
motor neurons with Golgi fragmentation, CTB codistribu-
ted with GM130 (Figure 1F, G). However, in a subset of
CTB-positive motor neurons with Golgi fragmentation,
CTB poorly codistributed with GM130 (Figure 1H). In
these cells, CTB was distributed in large clusters into the
cell body, in lysosomes, and diffusely throughout the
somato-dendritic compartment (Figure 1H).
We also performed double-labelling of CTB with
αCGRP (calcitonin-gene related peptide), a peptide that is
present in the trans-Golgi and secretory granules of most
large motor neurons [47]. Consistent with the results of
GM130-CTB double labelling, the majority of CTB-
positive motor neurons with Golgi fragmentation showed
codistribution of CTB and CGRP in the Golgi apparatus,
while in a small subset of CTB-positive motor neurons
with fragmented Golgi apparatus, CTB poorly colocalized
with CGRP (Figure 1I). Together, these data indicate that
although motor neurons with a fragmented Golgi can take
up, retrogradely transport and redistribute the tracer
throughout the somatodendritic compartment, a subset of
neurons with fragmented Golgi may have compromised
retrograde transport to the Golgi apparatus. The data also
indicate that motor neurons with Golgi fragmentation
may represent different stages of degeneration varying
from near-normal cells to cells in a more progressed de-
generative state (see below).
A larger proportion of dendrites with Golgi apparatus in
motor neurons with Golgi fragmentation
The presence of CTB enabled to easily distinguish the
proximal dendrites extending from the motor neurons.A subset of motor neurons in both non-transgenic and
G1del mice showed one or more GM130-positive ribbons
that entered the proximal dendrite and coursed up to the
first branching point (Figure 1J). Also motor neurons with
Golgi fragmentation showed Golgi apparatus entering the
proximal dendrites. In these cells the dendritic Golgi al-
ways was fragmented into smaller elements (Figure 1K).
Random sampling of motor neurons with 3 or more prox-
imal dendrites extending from the cell body in the plane
of section, indicated that motor neurons with Golgi frag-
mentation more often showed dendrites with Golgi appar-
atus (10 of 24 versus 12 of 14 analyzed motor neurons
with normal or fragmented Golgi apparatus, respectively;
see Additional file 1: Table S1). The mean number of den-
drites per sampled cell was the same for cells with or with-
out Golgi fragmentation (3.5 ± 0.14 versus 3.7 ± 0.24 for
normal or fragmented Golgi apparatus, respectively; non-
significant, unpaired student's t-test; see Additional file 1:
Figure S1). Overall, dendritic Golgi apparatus occurred 3
times more often in motor neurons with fragmented Golgi
(Additional file 1: Table S1 and Figure S1). These data sug-
gest that motor neurons with Golgi fragmentation show
an increased probability of extending the Golgi apparatus
in one or more proximal dendrites.
Golgi fragmentation precedes the appearance of
ubiquitin-positive inclusions in the cell body of
motor neurons
We have previously shown that the onset of Golgi fragmen-
tation in G1del mice grossly coincides with the onset of
other pathological signs, i.e. the appearance of somatoden-
dritic ubiquitinated SOD1 inclusions, the induction of
stress transcription factor ATF3 expression, and signs of
microglia activation at about 14–15 weeks of age [29,31,38].
For comparison, also in the high-copy fast G1 mouse the
onset of Golgi fragmentation at post-natal day 30 [27] coin-
cides with the onset of ATF3 expression, signs of ER stress
and microglia activation [48]. In G1del mice, ubiquitinated
SOD1 inclusions initially and most frequently occur in the
dendrites of motor neurons, while inclusions in the cell
body are relatively infrequent even in symptomatic animals
(>24 weeks) [29,31,38]. In these cells, ubiquitin labelling is
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into a dendrite, or is diffusely distributed throughout the
cell body [29]. While, ‘ubiquitinated’ motor neurons are
relatively rare and represent only a minority of motor neu-
rons with fragmented Golgi, inversely ubiquitinated motor
neurons in all occasions show Golgi fragmentation [29]. In
addition, the ubiquitinated motor neurons frequently show
a flattened and eccentric nucleus, suggestive of a progressed
stage of degeneration [29]. To determine whether the ubi-
quitinated motor neurons are still capable of retrogradely
transporting CTB, we double-labeled spinal cord sections
from CTB-injected mice for CTB and ubiquitin. Ubiquiti-
nated motor neurons that were also CTB-positive were
identified in sections from 20 and 25 weeks old G1del mice
(Figure 2A, B; 13 double-labeled cells in 24 lumbar L4 sec-
tions: 4 sections/mouse with 3 mice/age group), but not in
sections from 15 weeks old G1 del mice (16 sections from
4 mice; 4 sections/mouse). Ubiquitinated aggregates also
occurred in CTB-positive dendrites, sporadically in 15
weeks old mice, and more frequently in 20 and 25 weeks
old G1del mice (Figure 2C). These date indicate that even
motor neurons with severe ubiquitin pathology may have a
relatively intact axon in G1del mice, and that the presence
of ubiquitin pathology in more distal dendrites still allows
trafficking of CTB to this dendrite.
To analyze the relationship between Golgi fragmenta-
tion and the accumulation of misfolded SOD1 species, we
performed double labeling of GM130 with antibodies
against SOD1 dimer interface (SEDI, [37]) and unfolded
beta barrel domain of SOD1 (USOD, [36]). The USOD
antibody mainly stained vacuolated mitochondria in the
axon and distal dendrites, and, in addition, produced dif-
fuse staining in the cell bodies of motor neurons and
lightly stained ubiquitinated inclusions (not shown). The
SEDI antibody, apart from light staining of vacuolated
mitochondria and some background staining of astrocytic
processes, selectively immunoreacted with the ubiquiti-
nated inclusions (not shown). Similar to ubiquitinated epi-
topes, the presence of SEDI immunoreactive inclusions in
proximal dendrites or cell body in all occasions was asso-
ciated with Golgi fragmentation (Figure 2D).
To further establish the relationship between Golgi
fragmentation and the presence of ubiquitin-positive in-
clusions, we analyzed Golgi fragmentation in spinal
cord section of T3hSOD1 mice that express a relatively
low level of G93A mutant SOD1 specifically in neurons
and, in addition, ubiquitously express high levels of
wild-type SOD1 [31]. T3hSOD1 mice develop signs of
muscle weakness starting from 1 year of age, while den-
dritic ubiquitinated inclusions are already present in a
small number of motor neurons at the age of 20 weeks
[31,38]. T3hSOD1 showed fragmented Golgi apparatus
in a subset of motor neurons. The number of neurons
with fragmented Golgi increased with aging, and asubset of these also showed ubiquitin positive inclu-
sions in the cell body (Figure 2E-G). Importantly, simi-
lar to G1del mice, all motor neurons in T3hSOD1 mice
with ubiquitin-positive inclusions in the cell body or prox-
imal dendrites showed fragmented Golgi apparatus, while
inversely, only a subset of T3hSOD1 motor neurons with
fragmented Golgi apparatus show ubiquitin-positive inclu-
sions in the cell body or proximal dendrites.
Golgi fragmentation does not depend on ATF3 expression
Double-labeling with CTB with an antibody against ATF3
or activated phagocytosing microglia (Mac-2 positive, [38])
revealed CTB-positive motor neurons that expressed ATF3
or were contacted by phagocytosing microglia (Figure 3),
indicating that also these pathological signatures precede
distal axon degeneration. Double-labeling of ATF3 and
GM130 showed that consistent with previous data [29]
most (>80%) ATF3-positive motor neurons also have
fragmented Golgi (Figure 3A). Inversely, however, many
motor neurons with fragmented Golgi were ATF3-
negative (Figure 3B). Counting of lumbar sections of
G1del mice aged 20 (n = 3) and 25 weeks (n = 3) indi-
cated ATF3 expression in 40 ± 6 (25–62) % (Mean ± SE,
range) and 54 ± 13 (37–75) % of motor neurons with
Golgi fragmentation. Analysis of ATF3 and ubiquitin
double labeled sections indicated that all motor neurons
with ubiquitinated aggregates in the cell body are ATF3
positive. Since motor neurons with ubiquitinated aggre-
gates always show Golgi fragmentation, together the
data suggest that Golgi fragmentation occurs indepen-
dently from ATF3 expression in a significant proportion
of motor neurons, but codistributes with ATF3 in motor
neurons with ubiquitinated aggregates.
Golgi fragmentation in SOD-ALS mice does not depend
on apoptotic pathways
There is substantial evidence of early activation of apop-
totic pathways in SOD1-ALS mice [49,50], and accor-
dingly complete blockade of the mitochondrial apoptotic
pathway through deletion of both BAX and BAK attenu-
ated motor neuron loss and extended survival in high copy
(fast) G1 mice [33]. Analysis of archival paraffin spinal
cord sections from 90 days old G1 BAX-BAK double KO
mice from the study by Reyes et al. [33] revealed that these
mice still show Golgi fragmentation (Figure 4A-C), indi-
cating that Golgi fragmentation in G1 mice does not
depend on a functional mitochondrial apoptotic pathway.
Golgi fragmentation in apoptosis may depend on caspase
3 mediated cleavage of several membrane tethering factors
involved in the structural organization of the Golgi, in par-
ticular GRASP65 and p115 [16,51,52]. We therefore exam-
ined whether motor neurons with Golgi fragmentation
show reduced expression of these proteins. However, there
was no evidence for a relative reduction of GRASP65 (not
Figure 2 (See legend on next page.)
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Figure 2 CTB tracing and Golgi fragmentation in motor neurons with ubiquitinated SOD1-inclusions. A-C) Double-labeling confocal
image of CTB and ubiquitinated epitopes showing a CTB-positive motor neuron with a large inclusion in the proximal dendrite (A' and A''),
a CTB-positive motor neuron with intense ubiquitin labeling throughout most of the somato-dendritic compartment (B' and B''''), and
ubiquitin-labeling in distal CTB-positive dendrites (C-C'''). D) Double-labeling confocal image of GM130 and misfolded SOD1 (SEDI epitope)
showing a motor neuron with fragmented Golgi and a large SEDI-immunoreactive inclusion. E-F) Confocal image showing motor neurons
labeled for ChAT with fragmented Golgi apparatus and poly-ubiquitinated epitope (arrow) in L4 lumbar spinal cord section of 20 (E) and 35
(F) weeks old T3hSOD1 mouse. G) Bar graph showing the number of Golgi fragmented motor neurons in L4 spinal cord sections of G1del
versus T3hSOD1 mice. Values represent Means ± SE from 3 mice per group. Note that no motor neurons with fragmented Golgi occur in
non-transgenic, T3 and hSOD1 mice at 35 weeks of age. Bars: 50 μm (A-C), 10 μm (D-F).
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motor neurons. Together the data suggest no major role of
apoptotic pathways in triggering Golgi fragmentation in G1
mice motor neurons.
Golgi fragmentation is facilitated in SOD1-ALS mice with
reduced dynein/dynactin function
Fragmentation and dispersion of the Golgi apparatus is a
well established consequence of inhibition of the dynein/
dynactin microtubule motor complex [53-55]. Accordingly,
we showed that impairment of dynein function via overex-
pression of the N-terminus of Bicaudal D2 (BICD2-N)
causes Golgi fragmentation in cultured neurons and in vivo
in motor neurons of transgenic BICD2-N mice [17,56].
Here we have analyzed the occurrence of Golgi fragmenta-
tion in double transgenic G1del/BICD2-N mice resulting
from crossing of G1del mice with BICD2-N mice from the
BN1 line. Of note, BN1 mice show expression of theFigure 3 CTB tracing and Golgi fragmentation in motor neurons expr
Confocal image showing a CTB-positive motor neuron with fragmented Go
neurons with fragmented Golgi that are ATF3-negative (arrows) and a mot
Maximal projections of confocal stacks showing CTB-positive motor neuronBICD2-N transgene in 50-60% of the motor neurons,
and show Golgi fragmentation only in a small propor-
tion (1-10% depending on the age) of transgenic motor
neurons [17]. Significantly, more than 50% of BICD2-N-
expressing motor neurons showed Golgi fragmentation
in G1del/BN1 mice (Figure 5), which is a much larger
proportion than in BICD2-N-negative motor neurons in
the same mice, and in motor neurons of G1del littermates
(Figure 5B). These data indicate that impaired dynein/
dynactin function facilitates the process causing Golgi
fragmentation in G1del mice, or vice versa, and suggest
that Golgi fragmentation in G1del mice is related to im-
paired dynein-dynactin dependent trafficking.
Reduced numbers of endosomes in cells with
Golgi fragmentation
Inhibition of dynein-dynactin function, in addition to
Golgi fragmentation also causes relocalization of otheressing ATF3 or contacted by phagocytosing microglia. A)
lgi and ATF3-positive nucleus (arrow). B) Confocal image of motor
or neuron with a normal Golgi apparatus that is ATF3-positive. C, D)
s contacted by Mac-2 positive microglial cells. Bars: 20 μm (A-C).
Figure 4 Golgi fragmentation in SOD1-ALS mice is not downstream of apoptotic pathways. A, B) Confocal images of GM130 and ATF3
labeling in spinal motor neurons of a 90 day old fast SOD1-G93A mouse (G1 line) crossed into mouse deficient for BAK in all cells and BAX specifically
in neurons (DKO) resulting in deficiency of the mitochondrial apoptotic pathways. Note, motor neurons with normal (A) and fragmented (B) Golgi
apparatus and ATF3 expression in motor neurons with fragmented Golgi. C) G1-DKO showed a lower proportion Golgi fragmented motor neurons but
this difference was not significant (unpaired Student’s t-test); values are means ± SE (n = 3 mice per group). D) Confocal image of p115 and GM130
(N-terminus) double labeling in motor neurons in 25 week old G1del mouse showing that motor neurons with fragmented Golgi (insert) show the
same relative intensity of p115 staining. Bar: 10 μm.
Figure 5 Facilitated Golgi fragmentation in mice G1del motor neurons with impaired dynein function. A) Representative confocal image
of L4 lumbar motor neurons of a BN1/G1del transgenic mouse of 28 weeks of age. BN1 mice express GFP-BICD2-N in 50-60% of the motor neurons
[17]. Note, Golgi fragmentation in GFP-BICD2-N neurons and normal Golgi apparatus in the other motor neurons. Bar, 20 μm. B) Bar graph showing
the proportion of motor neurons with Golgi fragmentation in cervical C6/7 motor neurons of G1del, BN1, and G1del/BN1 mice of 28 weeks of age.
Note, a much larger proportion of motor neurons with Golgi fragmentation in GFP-BICD2-N-positive (+) motor neurons of G1del/BN1 mice as
compared to GFP-BICD2-N-negative (−) motor neurons of G1del/BN1 mice and motor neurons of G1del mice, which show similar percentages of
motor neurons with Golgi fragmentation. *, P < 0.01, compared to G1del and G1del/BN1- motor neurons, Tukey’s multiple comparison test after
one-way ANOVA. The difference in relative proportion of Golgi fragmentation can not be explained by differential degeneration of
GFP-BICD2-N-positive versus GFP-BICD2-N-negative neurons, as at this age there is minimal loss of cervical motor neurons in G1del mice
(Additional file 1: Figure S2).
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Figure 6 Reduced endosome levels in motor neurons with Golgi fragmentation. A, B) Confocal images of staining of the endosomal proteins EEA1
(A) and GRASP1 (B) in lumbar spinal cord sections of a BN1 transgenic mouse. Note reduced EEA1 and GRASP1 labeling in GFP-BICD2-N positive neurons.
C) Analysis of fluorescent intensities of GFP-BICD2-N positive versus negative motor neurons showed reduced mean intensities in GFP-BICD2-N positive
motor neurons (P < 0.05, unpaired Student's t-test negative (−) versus positive (+) neurons). Note that all values were collected from non-transgenic (n = 2
mice) and BN1 (n = 4) lumbar spinal cord specimen embedded in a single gelatin block and processed in the same immunorun (see Material and methods).
D-F) Quantitation (D) and representative images (E, F) of GRASP1-labeling in motor neurons with normal and fragmented Golgi showing reduced GRASP1
labeling in motor neurons with fragmented Golgi (P < 0.05, unpaired Student's t-test, normal versus fragmented Golgi). G, H) Confocal images of EEA1-labeling
in motor neurons with normal and fragmented Golgi showing reduced EEA1 labeling in motor neurons with fragmented Golgi. Bars, 10 μm.
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Figure 7 (See legend on next page.)
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Figure 7 Reduced endosome levels after dynein-dynactin inhibition. A-D) Primary hippocampal neurons expressing the dynactin subunit
p50 (GFP-p50), a dominant-negative dynactin construct (GFP-p150-cc1) or GFP-BICD2-N, show reduced EEA1 labelling and a lower EEA1 particle
density compared to GFP transfected and untransfected neurons (A). Inset shows enlargement of soma. Bar: 10 μm. E) Bar graph of the relative
particle density. ***, P < 0.001 compared to GFP group, Tukey’s multiple comparison test following one-way ANOVA (P < 0.001).
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impaired dynein-dynactin function redistribute to the cell
periphery in non-polarized cells [53-55]. We therefore
studied the distribution of endosomes in motor neurons
of BN1 and G1del mice using antibodies against early en-
dosome antigen 1 (EEA1) [57] and Rab4 binding protein
GRASP-1 [58,59]. Strikingly, instead of a redistribution of
endosomes to the cell periphery, BICD2-N-expressing
motor neurons in BN1 mice showed an overall reduction
of endosomal labeling in both EAA1 and GRASP1 stained
sections (Figure 6A-C). The same was observed in
motor neurons with Golgi fragmentation in G1del mice
which showed reduced levels of GRASP1 and EEA1
staining that correlated with the severity of Golgi frag-
mentation (Figure 6D-H). In both BICD2-N and G1del
mice, changes in endosomal labelling were most evident
in sections stained for GRASP-1, as reduced labelling
was associated with a loss of the relatively large parti-
cles. These data indicate that motor neurons with Golgi
fragmentation in G1del mice reproduce an additional
organelle abnormality that also occurs in motor neurons
with impaired dynein/dynactin function.
Reduced levels of endosomes in neurons after inhibition
of dynein/dynactin
The above data indicate a different effect of dynein/
dynactin inhibition on endosome distribution in neurons
versus non-polarized cells. To further substantiate these
differences, we examined the effect of dynein/dynactin in-
hibition on the distribution of endosomes in primary cul-
tured hippocampal neurons. In accord with reduced
endosomal labelling in motor neurons of BICD2-N mice,
inhibition of dynein-dynactin function in primary cultured
hippocampal neurons by overexpression of BICD2-N, the
dynactin subunit p50, or a dominant-negative dynactin
construct (p150-cc1) [17,39,53] also resulted in reduced la-
belling of the endosomal marker EEA1, rather than a redis-
tribution of endosomes to the cell periphery (Figure 7).
These data support the notion that reduced endosomal
labelling in motor neurons with Golgi fragmentation in
G1del mice may reflect impaired dynein/dynactin function.
Discussion
Golgi fragmentation is a well-established feature of ALS
spinal and cortical motor neurons, that also occurs in
some other neurodegenerative conditions, is reproduced
in SOD1-ALS mice and some cellular ALS models [6,60],
but is not found in degenerating motor neuron in a non-ALS disorder [61] and non-ALS mouse models [62]. Golgi
fragmentation in ALS and ALS mouse models also differs
from the large variety of Golgi apparatus morphological
abnormalities that we observed in motor neurons of a
DNA-repair deficient mouse model [63]. In motor neu-
rons of ALS patients, the presence of Golgi fragmentation
correlates with an abnormal TDP-43 distribution or the
presence of inclusions, suggesting a relationship between
Golgi fragmentation and the presence of protein aggre-
gates [22-24]. Accordingly, here we show in SOD1-ALS
mice that Golgi fragmentation occurs in all motor neurons
with ubiquitinated SOD1 inclusions. However, a major
portion of motor neurons with Golgi fragmentation did
not show such inclusions. This can be explained by the
presence of inclusions in dendrites that were not in the
plane of the section, or small aggregates that are not de-
tectable at the light microscopic level [64]. Alternatively,
Golgi fragmentation may be caused by a process upstream
of large aggregates, perhaps mediated by toxic misfolded
or oligomeric SOD1 species [64,65]. Using antibodies
against misfolded and aggregated SOD1 species (USOD
and SEDI, [36,37]), we did not detect changes that showed
a consistent correlation with Golgi fragmentation.
In the present study, we also show that motor neurons
with Golgi fragmentation more frequently display Golgi ap-
paratus within the proximal dendrite. Despite the limita-
tions of our analysis, in that we only analyzed the dendrites
in the transverse plane, the data indicate that the likelihood
for a proximal dendrite showing Golgi apparatus is 3 times
higher in cells with Golgi fragmentation. Data from hippo-
campal neurons indicate that the Golgi apparatus orients
toward the longest dendrite, and that the presence of the
Golgi apparatus and Golgi outposts (i.e. discrete compart-
ments that are discontinuous with somatic Golgi) into den-
drites relates to local secretory demands [9,66,67]. Thus the
increased presence of Golgi apparatus in dendrites and per-
haps also Golgi fragmentation may reflect a reorganization
of the secretory pathway in response to increased secretory
demands from specific dendrites, e.g. to repair dendritic
damage.
Several findings suggest that Golgi fragmentation in
SOD1-ALS motor neurons is associated with reorganized
or aberrant trafficking: First, fragmentation into ministacks
is reminiscent of Golgi fragmentation resulting from im-
paired dynein-dependent transport [6,17]. Second, a subset
of neurons with Golgi fragmentation, in spite of their ability
of take up, retrogradely transport, and redistribute the CTB
throughout the somatodendritic compartment, do not
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of impaired endosome to Golgi retrograde trafficking.
Third, we show a large increase in Golgi fragmentation in
G1del mouse crossed with a mouse model showing im-
paired dynein/dynactin dependent transport, indicative of
a synergistic interaction between the process causing
Golgi fragmentation and dynein-dynactin dependent traf-
ficking. Fourth, we show that motor neurons with Golgi
fragmentation like motor neurons with impaired dynein/
dynactin function show reduced expression of endosomal
markers. Of note, the endosomal changes that we ob-
served in motor neurons with impaired dynein/dynactin
function are different from those observed in cultured
non-neuronal cells with radially oriented microtubules.
The differences between neurons and other cells may fol-
low from differences in microtubule organization as well
as differences in endosomal functional pathways [68,69].
Previous data from BICD2-N transgenic mice sug-
gested Golgi fragmentation is not necessarily detrimen-
tal [17]. Furthermore, we showed that G1del mice
crossed with BICD2-N transgenic mice show increased
life span, which combined with the finding of the
present study that these mice show increased levels of
Golgi fragmentation, suggests that Golgi fragmentation is
not detrimental and perhaps reversible in SOD1-ALS
mice. A recent study demonstrates reversible Golgi frag-
mentation in hippocampal neurons cultured in hyperexcit-
able conditions [18]. Reversible Golgi fragmentation has
also been shown to be part of a cytoprotective DNA dam-
age response, where DNA damage protein kinase, DNA-
PK, via phosphorylation of the Golgi protein GOLPH3
enhances the interaction between GOLPH3 and the my-
osin MYO18A and facilitates Golgi vesiculation [19]. The
extent to which Golgi fragmentation in ALS motor neu-
rons also is part of a coordinated stress response, that for
instance is triggered by the presence of protein aggregates,
remains to be established.
Multiple pathological events have been identified in
SOD1-ALS mice models, including mitochondrial ab-
normalities, ER stress, proteotoxic stress, abnormal ion
and glutamate homeostasis, abnormal axonal trans-
port, axonal degeneration, and non-cell autonomous
toxic events mediated by glial cells, but the relation-
ship between these events, and the extent to which
they occur in SOD1-ALS and other ALS patients re-
mains to be established [70]. Golgi fragmentation is a
well established feature of ALS motor neurons. In the
present study we confirm that Golgi fragmentation is a
very early event that precedes ATF3 induction and de-
generation of the distal axon, and occurs independ-
ently of the activation of apoptosis pathways. These
data, for instance, challenge the notion that ALS pri-
marily is a dying back axonopathy as suggested by
some studies [40-42].Conclusions
Together the data indicate that Golgi fragmentation is a
very early event in the pathological cascade in ALS that is
associated with altered organization of intracellular traf-
ficking. We propose that Golgi fragmentation is an early
response to deleterious mechanisms shared by several
ALS forms. Further identification of the mechanisms up-
stream of Golgi fragmentation will provide important
insights in ALS pathogenesis.
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Additional file 1: Table S1. Number and % of proximal dendrites with
Golgi apparatus in motor neurons with or without Golgi fragmentation in
G1del SOD1-G93A mice. Figure S1. A larger proportion of dendrites with
Golgi apparatus in motor neurons with Golgi fragmentation. Retrogradely
CTB-GM130 double labeled motor neurons were sampled in lumbar L4
transverse sections from three G1del mice of 20 weeks, on the basis of
the presence of at least 3 dendrites within the plane of section with at
least 2 dendrites that could be followed to the first branching point.
Confocal stacks of CTB and GM130 stacks were collected, and cells were
analyzed for the occurrence of Golgi fragmentation and the presence of
dendritic GM130 labeling. Bar graphs are based on 24 and 14 motor
neurons with normal and fragmented Golgi apparatus, respectively.
The mean number of dendrites in the plain of sections was the same for
motor neurons with normal versus fragmented Golgi apparatus. However,
the proportion of dendrites with Golgi apparatus was higher in cells with
fragmented Golgi *, P < 0.01, Student’s t-test. Figure S2. Bar graph
showing the number of ChAT-labelled motor neurons in cervical C6/7
motor neurons of G1del, BN1, G1del/BN1 and non-transgenic mice aged
28 weeks. (see [17] for Materials and methods).
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